Clinical Trial Update: An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

View source ↗

Summary

An observational study conducted in Italy to assess the burden of drug-resistant partial epilepsy, sponsored by GlaxoSmithKline, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Partial | Status: COMPLETED